
NewGenIvf Group Limited
NewGenIvf Group Limited (NIVF) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001981662 · NIVF · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001981662 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
NewGenIvf Group Limited (NASDAQ: NIVF) has submitted 148 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001981662, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is NewGenIvf Group Limited's most comprehensive regulatory disclosure. The most recent NewGenIvf Group Limited 10-K was filed on 2026-03-31 for fiscal year ending 2026. Historical NIVF 10-K annual reports are available from 2023 through 2026.
Investors researching NewGenIvf Group Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
NIVF SEC Filings · 8 questionsNewGenIvf Group Limited (NIVF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 148 filings and access original documents at no cost. NewGenIvf Group Limited's CIK is 0001981662.